Earnings Feed
Start Free
Home/Filings/4/0001144204-09-034570
4//SEC Filing

DiCorleto Paul E 4

Accession 0001144204-09-034570

CIK 0001318641other
View on SEC.govCompany Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:27 PM ET

Size

9.2 KB

Accession

0001144204-09-034570

Insider Transaction Report

Form 4
Period: 2009-06-25
CLEVELAND BIOLABS INCCBLI
DiCorleto Paul E
Director
Transactions
  • Award

    Stock Options (Right to Buy)

    2009-06-25+35,000→ 105,000 total
    Exercise: $3.41From: 2009-06-25Exp: 2019-06-24→ Common Stock (35,000 underlying)
  • Award

    Stock Options (Right to Buy)

    2007-06-12+35,000→ 35,000 total
    Exercise: $9.40From: 2007-06-12Exp: 2017-06-11→ Common Stock (35,000 underlying)
  • Award

    Stock Options (Right to Buy)

    2008-04-29+35,000→ 70,000 total
    Exercise: $5.88From: 2008-04-29Exp: 2018-04-28→ Common Stock (35,000 underlying)

Documents

1 file

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

→
Entity typeother

Related Parties

1
  • filerCIK 0001370082

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:27 PM ET
Size
9.2 KB
View on SEC.gov